Mid-term results of valve replacement with the ATS valve: A seven-year follow Up

Journal of Heart Valve Disease

Volumn 16, Issue 3, 2007, Pages 267-274

  Aoyagi, Shigeaki ^a   Hori, Hidetsugu ^a   Yoshikawa, Kazuhiro ^a   Arinaga, Koichi ^a   Fukunaga, Shuji ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; WARFARIN;

ADOLESCENT; ADULT; AGED; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; BRAIN HEMORRHAGE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENDOCARDITIS; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HEMATOTHORAX; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; MITRAL VALVE STENOSIS; MORTALITY; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROBABILITY; PROSTHESIS INFECTION; REOPERATION; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE; SURVIVAL RATE; THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AORTIC VALVE; ENDOCARDITIS; FEMALE; FOLLOW-UP STUDIES; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEMORRHAGE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE; PROSTHESIS FAILURE; PROSTHESIS-RELATED INFECTIONS; REOPERATION; RETROSPECTIVE STUDIES; THROMBOEMBOLISM; THROMBOSIS; TREATMENT OUTCOME;

EID: 34249984117     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Emery RW, Van Nooten GJ, Tesar PJ. The initial experience with the ATS Medical mechanical valve prosthesis. Ann Thorac Surg 2003;75:444-452
2. Emery RW, Krogh CC, Jones DJ, Nicoloff DM, Blake DP, Arom KV. Five-year follow up of the ATS mechanical heart valve. J Heart Valve Dis 2004;13:231-238
3. Aoyagi S, Arinaga K, Fukunaga S, Tayama E, Kosuga T, Akashi H. Leaflet movement of the ATS valve in the aortic position: Unique behavior observed in 19-mm valves. Ann Thorac Surg 2006;82:853-857
4. Edmunds LH, Jr., Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 1996;62:932-935
5. Ozeren M, Dogan OV, Dolgun A, Kocyldirim E, Karapinar K, Yucel E. Clinical results of the ATS prosthetic valve in 240 implants and review of the literature. J Heart Valve Dis 2001;10:628-635
6. Baykut D, Grize L, Schindler C, Keil AS, Bernet F, Zerkowski H-R. Eleven-year single-center experience with the ATS open pivot bileaflet heart valve. Ann Thorac Surg 2006;82:847-852
7. Tominaga R, Kurisu K, Ochiai Y, et al. A 10-year experience with the CarboMedics cardiac prosthesis. Ann Thorac Surg 2005;79:784-789
8. Laczkovics A, Heidt M, Oelert H, et al. Early clinical experience with the On-X prosthetic heart valve. J Heart Valve Dis 2001;10:94-99
9. Aoyagi S, Oryoji A, Nishi Y, Tanaka K, Kosuga K, Oishi K. Long-term results of valve replacement with the St. Jude Medical valve. J Thorac Cardiovasc Surg 1994;108:1021-1029
10. Koertke H, Koefer R. International normalized ratio self-management after mechanical heart valve replacement: Is an early start advantageous? Ann Thorac Surg 2001;72:44-48
11. Stefanidis C, Nana AM, Canniere DD, Antoine M, Jansens J-L, Huynh C-H. 10-year experience with the ATS mechanical valve in the mitral position. Ann Thorac Surg 2005;79:1934-1938
12. Van Nooten GJ, Van Belleghem Y, Caes F, et al. Lower-intensity anticoagulation for mechanical heart valves: A new concept with the ATS bileaflet aortic valve. J Heart Valve Dis 2003;12:495-502
13. Altman R, Rouvier J, Gurfinkel E, Scazziota A, Turpie A. Comparison of high-dose with low-dose aspirin in patients with mechanical heart valve replacement treated with oral anticoagulant. Circulation 1996;94:2113-2116
14. Westaby S, Van Nooten G, Sharif H, Pillai R, Caes F. Valve replacement with the ATS open pivot bileaflet prosthesis. Eur J Cardiothorac Surg 1996;10:660-665
15. Grunkemeier G, Wu YX, Jin R. Statistical analysis of heart valve outcomes. J Heart Valve Dis 2002;11(suppl.1):S2-S7
16. Gohlke-Barwolf, Acar J, Oakley C, et al. Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 1995;16:1320-1330
17. American College of Cardiology/American Heart Association. ACC/AHA guidelines for the management of patients with valvular heart disease: A report of American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Am Coll Cardiol 1998;32:1486-1588
18. Matsuda H, Abe T, Kawazoe K, et al. Guidelines for surgical and interventional treatment of valvular heart disease (JCS 2002). Circ J 2002;66(suppl.IV):1261-1323